BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 22, 2017
View Archived Issues
European Commission approves new single-dose delivery option for Repatha
Read More
Lanthio Pharma initiates first-in-human trial of MOR-107
Read More
Symptom improvement seen with etrolizumab in phase III study
Read More
Valeant Pharmaceuticals enters another EGP-437 licensing agreement with EyeGate
Read More
Researchers present safety, efficacy data for hydroxychloroquine plus aldesleukin in mRCC
Read More
Gilead tests novel non-catalytic site integrase inhibitor GS-9822 in vivo
Read More
Sarepta Therapeutics agrees to sell priority review voucher to Gilead Sciences
Read More
CureGrail launches with focus on diabetes
Read More
Adapt Pharma applies for E.U. approval of naloxone HCl nasal spray
Read More
FDA accepts Carbavance NDA for priority review
Read More
CohBar's lead candidates show promise in preclinical studies in NASH model
Read More
Protalex gives update on studies of PRTX-100 in ITP
Read More
Phase II results do not support further development of topical CD-101 for acute VVC
Read More
MJFF awards grant to FORMA Therapeutics for Parkinson's research
Read More
Pfizer's BLA for inotuzumab ozogamicin granted priority review by FDA
Read More
EMA grants orphan drug designation to LYS-GM101 for the treatment of GM1 gangliosidosis
Read More
Cellect Biotechnology reports positive final results from clinical trial of ApoGraft
Read More
Apitope reports results from phase IIa study of ATX-MS-1467
Read More
Trevena reports promising topline phase III data on oliceridine
Read More
FDA grants fast track status to Vericel's ixmyelocel-T
Read More
Novel Wnt signaling and IL-6 production inhibitors patented by Samumed
Read More
NewLink Genetics presents phase I data on HyperAcute Renal immunotherapy in patients with RCC
Read More
XBiotech can continue phase III study of Xilonix for treatment of colorectal cancer
Read More
VBL Therapeutics reports full results from exploratory phase II study of VB-111
Read More